ArticlePloS one2025

Matching of XEN®45 and PRESERFLO™ MicroShunt cases: Outcomes of a 3-year follow-up.

Cemre Altas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.